Exelixis’ next-generation tyrosine kinase inhibitor zanzalintinib is being tested for colorectal cancer, renal cell carcinoma ...

The European Commission granted approval for von Hippel-Lindau-associated renal cell carcinoma, CNS hemangioblastomas, or pancreatic neuroendocrine tumors.

Another antibody drug conjugate disitamab vedotin (an anti-HER2 antibody drug conjugate with MMAE payload) has also been shown to potentially pair well with immunotherapy. Disitamab vedotin + ...

Newly published detailed clinical trial data show why Exelixis abandoned a plan to seek an FDA approval for a combination of ...

The symptoms of pancreatic cancer can be nonspecific, which means identifying the disease is often a challenge.

Rezolute advances therapies for hypoglycemia with RZ358 and RZ402, showing efficacy in trials. Read why RZLT stock is a ...

Researchers have found that some particularly aggressive lung cancer cells can develop their own electric network, like that seen in the body's nervous system.

To honor reporter Jessica A. York and her work for the Sentinel and in the community, the Santa Cruz County Heroes series ...

The following is a summary of “Transcriptional regulatory network analysis identifies GRN as a key regulator bridging chemotherapy and immunotherapy response in small cell lung cancer,” published in ...

Researchers from the Francis Crick Institute have found that some particularly aggressive lung cancer cells can develop their ...

Background: Neuroendocrine carcinoma of the cervix (NECC ... to a training cohort and an internal validation cohort in a ratio of 7:3. Data from Fujian Cancer Hospital was used as an external ...

Dr. Boris Naraev, a medical oncologist specializing in patient care for those suffering from gastrointestinal, neuroendocrine and endocrine tumors, has joined Tampa General Hospital’s (TGH) Cancer ...